12-132510392-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_001367871.1(FBRSL1):c.489+2042A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000185 in 1,079,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001367871.1 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBRSL1 | NM_001367871.1 | c.489+2042A>G | intron_variant | ENST00000680143.1 | NP_001354800.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBRSL1 | ENST00000680143.1 | c.489+2042A>G | intron_variant | NM_001367871.1 | ENSP00000505341 | A2 | ||||
FBRSL1 | ENST00000434748.2 | c.489+2042A>G | intron_variant | 1 | ENSP00000396160 | P2 | ||||
FBRSL1 | ENST00000542061.2 | c.1419A>G | p.Arg473= | synonymous_variant | 4/4 | 2 | ENSP00000490180 | |||
FBRSL1 | ENST00000650108.1 | c.489+2042A>G | intron_variant | ENSP00000496901 | A2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000185 AC: 2AN: 1079690Hom.: 0 Cov.: 30 AF XY: 0.00000196 AC XY: 1AN XY: 509728
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | FBRSL1: PM2:Supporting, BP4, BP7 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.